# Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

> **NCT06691243** · PHASE2 · RECRUITING · sponsor: **University of Maryland, Baltimore** · enrollment: 40 (estimated)

## Conditions studied

- Cocaine Use Disorder
- HIV

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06691243
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-07
- **Primary completion:** 2026-07
- **Final completion:** 2027-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-08-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06691243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06691243, "Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06691243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*